7,8-(methylenedioxy)-14-hydroxyberbane

structure given in first source

Also Known As:

7,8-(methylenedioxy)-14 alpha-hydroxyalloberbane HCl; CH 38083; CH-38083; 6H-Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizin-11-ol, 5,8,8a,9,10,11,12,12a,13,13a-decahydro-, (8aS-(8aalpha,11alpha,12aalpha,13aalpha))-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Benzylisoquinolines: 151
    - Berberine Alkaloids: 9
      - Berberine: 2524
        7,8-(methylenedioxy)-14-hydroxyberbane: 2
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Berberine Alkaloids: 9
      - Berberine: 2524
        7,8-(methylenedioxy)-14-hydroxyberbane: 2

Related Diseases

1.	Tachycardia (Tachyarrhythmias) 04/01/1989 - "1. The prejunctional alpha 2-adrenoreceptor antagonist activity of CH-38083 (7,8-(methylenedioxi)-14-alpha-hydroxyalloberbane HCl), idazoxan and prazosin was determined against B-HT 920 on the tachycardia induced by cardiac nerve stimulation in pithed rats. "
2.	Body Weight (Weight, Body) 12/01/1995 - "In experiments 1 and 2 intruders smaller in body weight than the residents were treated with 0.0, 0.5, and 1.0 mg/kg CH-38083 and idazoxan, respectively; in experiment 3 weight matched intruders were injected with 1 mg/kg CH-38083 or idazoxan. "

Related Drugs and Biologics

1.	Idazoxan
2.	Prazosin (Minipress)
3.	talipexole